Literature DB >> 9456523

Relating cocaine blood concentrations to toxicity--an autopsy study of 99 cases.

S B Karch1, B Stephens, C H Ho.   

Abstract

UNLABELLED: We conducted a retrospective study of 48 men with cocaine-related deaths (CTOX), and a control group of 51 male cocaine users who died of lethal trauma (TRAU). Regression analysis and multiple t-tests were used to assess the relationship between cocaine and benzoylecgonire concentrations as well as autopsy measurements.
FINDINGS: Mean age was similar (35.9 vs 34.8 years, p = .549). Cocaine blood concentrations were not significantly different (1.12 vs .487 mg/L, p = .10), but mean BE concentrations were higher in CTOX (1.54 vs .946 mg/L, p = .018). CTOX decedents had a lower Body Mass Index (BMI) (24.6 vs 30.6, p = < .0001), larger hearts (426 vs 369, p = .009), and heavier lungs, livers, and spleens (1275 g vs 1007 g, p = .009, 1896 g vs 1628 g, p = .008, 193 g vs 146 g, p = .001).
CONCLUSIONS: (1) Blood cocaine concentrations in cocaine-related deaths are indistinguishable from postmortem concentrations in recreational users, but BE is higher in cocaine-related deaths. (2) Increased lung, liver and spleen weights are consistent with cocaine induced heart failure, but (3) Decreased BMI and increased heart weights in CTOX must be a consequence of long term cocaine use. Cardiac alterations may explain why equal blood cocaine concentrations may be lethal in some cases and innocuous in others, (4) Isolated measurements of postmortem cocaine and BE blood concentrations cannot be used to assess, or predict toxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456523

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  19 in total

1.  Cocaine: history, use, abuse.

Authors:  S B Karch
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

2.  The problem of methamphetamine toxicity.

Authors:  S Karch
Journal:  West J Med       Date:  1999-04

3.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

4.  Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Authors:  Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

5.  Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.

Authors:  Christian Lood; Grant C Hughes
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

6.  Exercise stress testing in recently abstinent chronic cocaine abusers.

Authors:  Praveen Kanneganti; Richard A Nelson; Susan J Boyd; Roy C Ziegelstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

7.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

8.  Acute excited states and sudden death. Death after restraint can be avoided.

Authors:  D Pounder
Journal:  BMJ       Date:  1998-04-11

9.  Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.

Authors:  Gregory T Collins; Matthew E Zaks; Alyssa R Cunningham; Carley St Clair; Joseph Nichols; Diwahar Narasimhan; Mei-Chuan Ko; Roger K Sunahara; James H Woods
Journal:  Drug Alcohol Depend       Date:  2011-04-11       Impact factor: 4.492

10.  "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Authors:  C M Milroy
Journal:  Forensic Sci Med Pathol       Date:  2011-01-25       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.